Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-04-29 4:57 pm Purchase | 13D | INCYTE CORPORATION INCY | BAKER BROS. ADVISORS LP | 32,581,959 15% | 30,374 (+0.09%) | View |
2020-04-24 4:32 pm Sale | 13D | SEATTLE GENETICS INC SGEN | BAKER BROS. ADVISORS LP | 50,423,593 29.2% | -881,639 (-1.72%) | View |
2020-03-25 4:46 pm Purchase | 13D | ZYMEWORKS INC ZYME | BAKER BROS. ADVISORS LP | 4,862,414 9.99% | 680,542 (+16.27%) | View |
2020-02-26 5:09 pm Purchase | 13D | KODIAK SCIENCES INC KOD | BAKER BROS. ADVISORS LP | 11,574,537 26.3% | 377,249 (+3.37%) | View |
2020-02-14 4:14 pm Purchase | 13G | MERUS N V COM MRUS | BAKER BROS. ADVISORS LP | 2,037,469 7.1% | 877,455 (+75.64%) | View |
2020-02-14 4:14 pm Sale | 13G | AMARIN CORP PLC SPONSORED ADR AMRN | BAKER BROS. ADVISORS LP | 34,620,057 9.6% | -7,972,767 (-18.72%) | View |
2020-02-14 4:14 pm Purchase | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | BAKER BROS. ADVISORS LP | 3,390,270 7.1% | 552,918 (+19.49%) | View |
2020-02-14 4:14 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | BAKER BROS. ADVISORS LP | 0 0% | -4,917,700 (Position Closed) | View |
2020-02-14 4:14 pm Purchase | 13G | HERON THERAPEUTICS INC HRTX | BAKER BROS. ADVISORS LP | 7,979,853 8.7% | 1,071,609 (+15.51%) | View |
2020-02-14 4:14 pm Sale | 13G | PRINCIPIA BIOPHARMA INC PRNB | BAKER BROS. ADVISORS LP | 1,808,684 5.5% | -61 (-0.00%) | View |
2020-02-14 4:14 pm Purchase | 13G | KRYSTAL BIOTECH INC KRYS | BAKER BROS. ADVISORS LP | 1,034,674 6% | 250,000 (+31.86%) | View |
2020-02-14 4:14 pm Purchase | 13G | ATRECA INC BCEL | BAKER BROS. ADVISORS LP | 3,532,760 16% | 3,532,760 (New Position) | View |
2020-02-14 4:14 pm Purchase | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | BAKER BROS. ADVISORS LP | 15,875,125 9.99% | 703,585 (+4.64%) | View |
2020-02-14 4:14 pm Purchase | 13G | INVITAE CORP COM NVTA | BAKER BROS. ADVISORS LP | 9,222,078 9.5% | 4,336,525 (+88.76%) | View |
2020-02-14 4:14 pm Purchase | 13G | INFLARX N V COM IFRX | BAKER BROS. ADVISORS LP | 1,778,415 6.8% | 1,778,415 (New Position) | View |
2020-02-14 4:14 pm Sale | 13G | AEVI GENOMIC MEDICINE INC GNMX | BAKER BROS. ADVISORS LP | 564,844 0.7% | -3,385,575 (-85.70%) | View |
2020-02-14 4:14 pm Unchanged | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | BAKER BROS. ADVISORS LP | 1,713,604 5.9% | 0 (Unchanged) | View |
2020-02-14 4:14 pm Purchase | 13G | ZYMEWORKS INC ZYME | BAKER BROS. ADVISORS LP | 4,181,872 9.99% | 2,473,400 (+144.77%) | View |
2020-02-14 4:14 pm Sale | 13G | CONTRAFECT CORP CFRX | BAKER BROS. ADVISORS LP | 5,553,599 3.5% | -2,465,977 (-30.75%) | View |
2020-01-24 5:18 pm Sale | 13D | BELLICUM PHARMACEUTICALS INC C BLCM | BAKER BROS. ADVISORS LP | 2,491,244 4.99% | -186,574 (-6.97%) | View |